It was definitely a big week – corporations had to boost over $100 million to make the list. Startups related to biotechnology and healthcare are at the forefront – they dominate the list, taking over the overwhelming majority of places. However, as usual, it is the company related to AI that comes out on top.
1. DDNUSD 300 million, data storage: Data is a big money game lately. Private equity giant Blackstone Group makes a strategic investment of USD 300 million DDNvaluing the Chatsworth, California-based data storage company at $5 billion. Founded in 1998, DDN — formerly called DataDirect Networks — helps corporations store, analyze and manage data, a high-value commodity as more corporations look to build and train artificial intelligence models. The company plans to make use of the latest money to expand across industries, from healthcare to autonomous vehicles, and speed up product innovation, including its AI-powered data analytics platform. Of course, this is not the only play Blackstone Group has made in the data sector. This was the case last yr reported the world’s largest asset manager plans to speculate $8.2 billion in the development of data centers in Spain. In 2023 it is cooperated With Digital reality build $7 billion value of data centers aimed at providers of online content, cloud services and artificial intelligence. Blackstone is also a supporter CoreWeavean artificial intelligence infrastructure startup that gives access to highly sought-after AI chips from Nvidia.
2. Innovator$275 million, health care: San Francisco-based Innovaccer may very well be classified as artificial intelligence or healthcare as the company goals to be a “one-stop shop” for AI solutions in healthcare. Innovaccer, which helps healthcare organizations by providing software solutions that aim to enhance the patient experience and reduce administrative burdens for healthcare providers, raised $275 million across primary and secondary care. No lead investor has been announced, but investors have been included Capital B AND Kaiser Permanente. Founded in 2014, the company has raised $654 million, via Crunchbase.
3. WhatnotUSD 265 million, e-commerce: While most of us wish to in the reduction of on spending after the holidays, investors clearly consider that individuals wish to spend extra money on Whatnot’s live shopping platform. The Los Angeles-based startup raised $265 million in Series E at a valuation of nearly $5 billion. He co-hosted the round Avra, Global summer time AND Greycroft. Whatnot’s annual gross merchandise value from live sales exceeded $3 billion last yr. Founded in 2019, Whatnot has raised roughly $746 million for the company.
4. Aviceda therapyUSD 208 million, biotechnology: It could also be a latest yr, but biotechnology is still gaining popularity. Cambridge, Massachusetts-based Aviceda Therapeutics, a biotechnology company focused on developing immunomodulators to alleviate chronic inflammation, announced the closing of a $207.5 million Series C project co-authored by: Omega Funds AND TCGX. Founded in 2018, the company has raised $277 million, via Crunchbase.
5. Tenvie therapy$200 million, biotechnology: South San Francisco-based Tenvie Therapeutics, a biotechnology company focused on treating neurological diseases, launched with $200 million in funding led by Arch Venture Partners, F-Prime capital AND The capital of Mubadala.
6. Timberlyne TherapyUSD 180 million, biotechnology: San Diego-based Timberlyne Therapeutics, a biopharmaceutical startup focused on developing therapies for autoimmune diseases, has closed a $180 million Series A led by Abingworth, Bain Capital Life Sciences AND Venrock Healthcare Capital Partners. This is the company’s first funding via Crunchbase.
7. InariUSD 144 million, agtech: Cambridge, Massachusetts-based Inari, a startup that designs more sustainable seeds for agriculture, has locked a $144 million round. No lead investor was named, but the company said one of the latest investors is a wholly owned subsidiary Abu Dhabi Investment Authority. The company is focusing on creating latest seeds for large-scale crops in its first wave of products – including soybeans, corn and wheat. Founded in 2016, Inari has raised $720 million for the company.
8. Hippocrates’ artificial intelligence$141 million, artificial intelligence: Palo Alto, California-based Hippocratic AI, which develops a multi-language security-focused model for healthcare, security and accuracy, raised $141 million in Series B funding, valuing the company at $1.6 billion. He led the round Little Perkins. Founded in 2023, the company has raised $276 million, via Crunchbase.
9. Evergreen Nephrology$130 million, health care: Nashville, Tenn.-based Evergreen Nephrology, which provides care for people with chronic kidney disease, raised $130 million led by HC/FT oak, Founders of Rubikon and a group of existing investors. Founded in 2021, the company raised $134 million, via Crunchbase.
10. Golden medicinesUSD 120 million, biotechnology: San Francisco-based Ouro Medicines, a biotechnology developing immune-resetting drugs for people with chronic immune-related diseases, has launched a $120 million Series A round co-led by: New employees of the company, Norwest Venture Partners AND TPG.
Great global offers
The largest funds outside the United States, in fact, went to a different biotechnology company.
- Based in London Bio Verdivaa company developing treatments for obesity and cardiometabolic diseases, raised $411 million in Series A funding.
Methodology
We tracked the largest announced rounds in the Crunchbase database that were raised by US-based corporations over a seven-day period from January 3 to January 10. Although most announced rounds are represented in the database, there could also be a slight delay as some rounds are reported late in the week.